跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
11a
首页
药物
11a
11a
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
11a, 12-derivatives of tetracycline compounds
申请人: BERNIAC JOEL
优先权: 2006
US
4 件公开
Type 11A pneumococcal monoclonal antibody and application thereof
申请人: SINOVAC RES & DEV CO LTD
优先权: 2014
CN
Methods of treating diabetes using pde 11a inhibitors
申请人: BAYER PHARMACEUTICALS CORP
优先权: 2003
US
Tanshinone 11A used in preparing medicine for preventing and treating atherosclerosis
申请人: UNIV ZHONGSHAN
优先权: 2001
CN
Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a (pde11a)
申请人: BAYER HEALTHCARE AG
优先权: 2002
US
Phosphorylation of histone H3 at threonine 11a novel epigenetic mark for transcriptional regulation
申请人: SCHUELE ROLAND
优先权: 2007
US
Bcl11a siRNA-585 for inhibiting B-cell lymphoma/leukemia 11A (BCL11A) expression and tumorous B cell proliferation and application thereof
申请人: UNIV JINAN
优先权: 2011
CN
OPHTHALMIC FORMULATION FOR TOPICAL USE CONTAINING HELENALIN, 11A,13-DIHYDRO HELENALIN AND FLAVONOIDS FROM ARNICA MONTANA EXTRACT AND SODIUM HYALURONATE, AND USE THEREOF BY HUMANS TO TREAT DRY EYE SYNDROME
申请人: CENTRO DE RETINA MEDICA Y QUIRURGICA S C
优先权: 2022
EP
药物
反馈